StockData
InnovAge Holding Corp. logo

InnovAge Holding Corp. (INNV) stock

INNVNasdaqServices-Health ServicesFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 11/3063% above fair value
$8.91−0.51 (-5.41%)

Close on Nov 18, 2026Market cap $1.22BP/E –Yield –

InnovAge revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

InnovAge's revenue for the twelve months ending Jun 30, 2026 was $989.71M, up 15.9% year over year. For fiscal 2026 it was $989.71M, up 15.9% from the year before. The highest annual figure on record is $989.71M in fiscal 2026.

Annual revenue

PeriodPeriod endValueChange
FY2026Jun 30, 2026$989.71M+15.9%
FY2025Jun 30, 2025$853.70M+11.8%
FY2024Jun 30, 2024$763.86M+11.0%
FY2023Jun 30, 2023$688.09M-1.5%
FY2022Jun 30, 2022$698.64M+9.5%
FY2021Jun 30, 2021$637.80M+12.4%
FY2020Jun 30, 2020$567.19M–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$261.95M+18.3%
Q3 FY2026CQ1 2026Mar 31, 2026$251.94M+15.5%
Q2 FY2026CQ4 2025Dec 31, 2025$239.71M+14.7%
Q1 FY2026CQ3 2025Sep 30, 2025$236.11M+15.1%
Q4 FY2025CQ2 2025Jun 30, 2025$221.42M+11.0%
Q3 FY2025CQ1 2025Mar 31, 2025$218.14M+13.0%
Q2 FY2025CQ4 2024Dec 31, 2024$209.00M+10.6%
Q1 FY2025CQ3 2024Sep 30, 2024$205.14M+12.4%
Q4 FY2024CQ2 2024Jun 30, 2024$199.40M+12.7%
Q3 FY2024CQ1 2024Mar 31, 2024$193.07M+11.9%
Q2 FY2024CQ4 2023Dec 31, 2023$188.90M+12.8%
Q1 FY2024CQ3 2023Sep 30, 2023$182.49M+6.6%
Q4 FY2023CQ2 2023Jun 30, 2023$176.87M+2.3%
Q3 FY2023CQ1 2023Mar 31, 2023$172.54M-2.7%
Q2 FY2023CQ4 2022Dec 31, 2022$167.46M-4.5%
Q1 FY2023CQ3 2022Sep 30, 2022$171.22M-1.1%
Q4 FY2022CQ2 2022Jun 30, 2022$172.86M+0.7%
Q3 FY2022CQ1 2022Mar 31, 2022$177.36M+13.5%
Q2 FY2022CQ4 2021Dec 31, 2021$175.35M+11.5%
Q1 FY2022CQ3 2021Sep 30, 2021$173.07M+13.4%
Q4 FY2021CQ2 2021Jun 30, 2021$171.62M+12.5%
Q3 FY2021CQ1 2021Mar 31, 2021$156.31M+8.0%
Q2 FY2021CQ4 2020Dec 31, 2020$157.31M–
Q1 FY2021CQ3 2020Sep 30, 2020$152.57M–
Q4 FY2020CQ2 2020Jun 30, 2020$152.49M–
Q3 FY2020CQ1 2020Mar 31, 2020$144.77M–

More InnovAge figures

See a number that looks wrong?